Pedro Cruz

Outlook

proteins bioprocess development preclinical models cell lines pilot plant analytical services nutraceuticals cell based assays viral vectors stem cells clinical atmps gene therapy cdmo bioactives bioplastics new materials virus cell therapy bioengineering production manufacturing vaccines biopharmaceuticals biotechnology research cell-based therapies bioprocess engineering drug discovery immunology microbiology molecular biology natural bioactives translational research advanced cell models protein biophysics sustainability r&d biotechnological solutions bioproduction technology transfer clinical trials heart cells cancer therapies innovative bioprocesses biotechnology infrastructure interdisciplinary teams innovation program phd training scientific advisory board biopharmaceutical development regenerative medicine therapeutic strategies microalgae cultivation antibody discovery drug efficacy preclinical assessment bioanalytics complex protein production advanced technologies high-throughput systems cancer models translational immunology biomanufacturing cell culture biomedical research health-promoting effects food safety environmental challenges biotechnology vaccine development advanced therapeutic medicinal products 3d cell models glp-grade production research & development global partnerships academic collaborations agri-food industry health sciences innovation scientific knowledge analytical methods complex biopharmaceuticals recombinant proteins preclinical studies gmp-certified production biotechnology solutions biopharma pharmaceutical industry health technology environmental sciences mechanical or industrial engineering environmental services renewables & environment health care health wellness & fitness hospital & health care